Spicer JD, Garassino MC, Wakelee H, Liberman M, et al. Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 Lancet 2024 Sep 12:S0140-6736(24)01756-2. doi: 10.1016/S0140-6736(24)01756.
PMID: 39288781